Company Overview and News

Del Monte Philippines postpones IPO to May

2018-04-09 bworldonline
DEL MONTE Pacific Ltd. (DMPL) is pushing back the stock market debut of its Philippine unit to give way to other big-ticket share sales in the market.
Upvote Downvote

Del Monte posts $40.4M in net loss

Campos family-led food conglomerate Del Monte Pacific Ltd. (DMPL) booked a net loss of $40.4 million in the nine-month period ending January, reversing the performance a year ago when it posted a net profit of $21.5 million.
Upvote Downvote

Del Monte Pacific swings to net loss in Q3

2018-03-08 bworldonline
DEL MONTE PACIFIC Limited (DMPL) swung to a net loss in the November to January period, as it felt the impact of new tax rates in the United States as well as the sale of its Arkansas-based vegetable business.
Upvote Downvote

DMPL incurs $40.4M net loss

Campos family-led food conglomerate Del Monte Pacific Ltd. (DMPL) booked a net loss of $40.4 million in the nine-month period ending January, a turnaround from the net profit of $21.5 million year-on-year, due to one-off expenses from the shutdown of underperforming US plants alongside the write-off of deferred US tax assets.
Upvote Downvote

D.M. Wenceslao files for P15.5-B IPO

2018-03-06 bworldonline
MANILA — Philippine property developer D.M. Wenceslao and Associates, Inc. on Tuesday flagged plans to go public by raising up to P15.5 billion ($300 million) in an initial public offering (IPO).
Upvote Downvote

More capital-raising activities expected in 2018

2018-02-27 bworldonline
CAPITAL RAISING in the Philippines is seen to increase this year as companies continue to tap investment banks in building their war chests.
Upvote Downvote

Mart volatility weighs on public float hike

2018-02-25 bworldonline
THE SECURITIES and Exchange Commission (SEC) still plans to raise the minimum public ownership (MPO) requirement of publicly listed companies by yearend, but recent market volatility has made corporate regulators cautious for now.
Upvote Downvote

Fresh Del Monte Produce's (FDP) CEO Mohammad Abu-Ghazaleh on Q4 2017 Results - Earnings Call Transcript

2018-02-20 seekingalpha
Fresh Del Monte Produce Inc. (NYSE:FDP) Q4 2017 Earnings Conference Call February 20, 2018 11:00 AM ET
Upvote Downvote

P16.7-B Del Monte IPO in the works

The Campos family is planning a P16.7-billion initial public offering (IPO) for food and beverage arm Del Monte Philippines Inc. (DMPI), a leading fruit, canned fruit, fruit juice and spaghetti sauce supplier in the country and operator of one of the world’s largest fully integrated pineapple production hubs.
Upvote Downvote

Del Monte Philippines files P16.72-B IPO

2018-02-06 philstar
MANILA, Philippines — The local unit of Del Monte Pacific Ltd. will embark on an initial public offering (IPO) this year to raise P16.72 billion.
Upvote Downvote

Del Monte’s Philippine unit to raise up to P16.7B in IPO

2018-02-06 bworldonline
DEL MONTE Pacific Limited (DMPL) is taking its Philippine unit public, with plans to raise up to P16.7 billion to repay debts.
Upvote Downvote

Del Monte PH plans P16.7B IPO

The Campos family is planning a P16.7-billion initial public offering for Del Monte Philippines Inc. (DMPI), a leading producer of canned fruit and juice drinks, tropical fruit, spaghetti sauce and tomato ketchup in the country.
Upvote Downvote

Bourse operator’s net profit grows 18% in 2017

2018-02-05 bworldonline
EARNINGS of the Philippine Stock Exchange, Inc. (PSE) grew by 18% in 2017, propped up by higher trading activity in the bourse as well as one-time gains from the sale of its Tektite office in Ortigas district.
Upvote Downvote

2017 PSE net foreign buying at P56B

The Philippine stock market attracted P56.21 billion in net foreign buying in 2017, a breakout year for local equities on the back of a benign global economic environment and a much-awaited local tax reform program that is seen to usher in a “golden age of infrastructure.”
Upvote Downvote

Del Monte Pacific raises $100M from preferred shares offer

2017-12-12 bworldonline
DEL MONTE Pacific Limited (DMPL) said it has completed its offering of Series A-2 preferred shares last Friday, raising $100 million in the process.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...